The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia

Endocrinology

Volumn 149, Issue 5, 2008, Pages 2208-2218

  Sauter, Nadine S ^a   Schulthess, Fabienne T ^a   Galasso, Ryan ^a   Castellani, Lawrence W ^a   Maedler, Kathrin ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; FATTY ACID; LEPTIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RESISTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DRUG MECHANISM; FOOD INTAKE; GLUCOSE TOLERANCE; HYPERGLYCEMIA; INSULIN RELEASE; LIPID DIET; MOUSE; NONHUMAN; PRIORITY JOURNAL; WEIGHT GAIN;

ADIPOKINES; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DIET, ATHEROGENIC; DISEASE PROGRESSION; DRUG EVALUATION, PRECLINICAL; EATING; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INSULIN-SECRETING CELLS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MICE; MICE, INBRED C57BL; WEIGHT GAIN;

EID: 42449091550     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1059     Document Type: Article

References (58)

1. Cerasi E, Luft R 1967 Insulin response to glucose infusion in diabetic and non-diabetic monozygotic twin pairs. Genetic control of insulin response? Acta Endocrinol (Copenh) 55:330-345
2. Taylor SI, Accili D, Imai Y 1994 Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 43:735-740
3. Gerich JE 2000 Insulin resistance is not necessarily an essential component of type 2 diabetes. J Clin Endocrinol Metab 85:2113-2115
4. Bonner-Weir S 2000 Islet growth and development in the adult. J Mol Endocrinol 24:297-302
5. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC 2003 β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110
6. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S 2002 Reduced β-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 45:85-96
7. Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, Yoo SJ, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim HS, Lee IK, Bonner-Weir S 2003 Selective β-cell loss and α-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300-2308
8. Kurrer MO, Pakala SV, Hanson HL, Katz JD 1997 β cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci USA 94:213-218
9. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC 2005 Sustained β cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48:2221-2228
10. Donath MY, Ehses JA, Maedler K, Schumann DM, Ellingsgaard H, Eppler E, Reinecke M 2005 Mechanisms of {beta}-cell death in type 2 diabetes. Diabetes 54(Suppl 2):S108-S113
11. Prentki M, Nolan CJ 2006 Islet β cell failure in type 2 diabetes. J Clin Invest 116:1802-1812
12. Halliwell B 1994 Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344:721-724
13. Rabinovitch A, Suarez WL, Power RF 1992 Combination therapy with an antioxidant and a corticosteroid prevents autoimmune diabetes in NOD mice. Life Sci 51:1937-1943
14. Sumoski W, Baquerizo H, Rabinovitch A 1989 Oxygen free radical scavengers protect rat islet cells from damage by cytokines. Diabetologia 32:792-796
15. Mandrup-Poulsen T 2001 β-cell apoptosis: stimuli and signaling. Diabetes 50(Suppl 1):S58-S63
16. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY 2002 Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860
17. Mandrup-Poulsen T 1996 The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029
18. Eizirik DL, Mandrup-Poulsen T 2001 A choice of death-the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia 44:2115-2133
19. Mine T MK, Okutsu T, Mitsui A, Kitahara Y 2004 Gene expression profile in the pancreatic islets of Goto-Kakizaki (GK) rats with repeated postprandial hyperglycemia. Diabetes 53(Suppl 2):2475A
20. Butler AE, Jang J, Gurlo T, Carty MD, Soeller WC, Butler PC 2004 Diabetes due to a progressive defect in β-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat): a new model for type 2 diabetes. Diabetes 53:1509-1516
21. Dinarello CA 1996 Biologic basis for interleukin-1 in disease. Blood 87:2095-2147
22. Donath MY, Storling J, Maedler K, Mandrup-Poulsen T 2003 Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 81:455-470
23. Eizirik DL, Tracey DE, Bendtzen K, Sandler S 1991 An interleukin-1 receptor antagonist protein protects insulin-producing β cells against suppressive effects of interleukin-1 β. Diabetologia 34:445-448
24. Giannoukakis N, Rudert WA, Ghivizzani SC, Gambotto A, Ricordi C, Trucco M, Robbins PD 1999 Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1β-induced β-cell impairment and activation of islet cell apoptosis in vitro. Diabetes 48:1730-1736
25. Dinarello CA 2000 The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med 343:732-734
26. Seckinger P, Lowenthal JW, Williamson K, Dayer JM, MacDonald HR 1987 Aurine inhibitor of interleukin 1 activity that blocks ligand binding. J Immunol 139:1546-1549
27. Seckinger P, Williamson K, Balavoine JF, Mach B, Mazzei G, Shaw A, Dayer JM 1987 A urine inhibitor of interleukin 1 activity affects both interleukin 1 α and 1 β but not tumor necrosis factor α. J Immunol 139:1541-1545
28. Arend WP, Guthridge CJ 2000 Biological role of interleukin 1 receptor antagonist isoforms. Ann Rheum Dis 59(Suppl 1):i60 -i64
29. Sandberg JO, Andersson A, Eizirik DL, Sandler S 1994 Interleukin-1 receptor antagonist prevents low dose streptozotocin induced diabetes in mice. Biochem Biophys Res Commun 202:543-548
30. Nicoletti F, Di Marco R, Barcellini W, Magro G, Schorlemmer HU, Kurrle R, Lunetta M, Grasso S, Zaccone P, Meroni P 1994 Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor. Eur J Immunol 24:1843-1847
31. Sandberg JO, Eizirik DL, Sandler S 1997 IL-1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non-obese diabetic (NOD) mice. Clin Exp Immunol 108:314-317
32. Stoffels K, Gysemans C, Waer M, Laureys J, Bouillon R, Mathieu C 2002 Interleukin-1 receptor antagonist inhibits primary non-function and prolongs graft survival time of xenogeneic islets transplanted in spontaneously diabetic autoimmune NOD mice. Diabetologia 45(Suppl 2):424-424
33. Maedler K, Sergeev P, Ehses JA, Mathe Z, Bosco D, Berney T, Dayer JM, Reinecke M, Halban PA, Donath MY 2004 Leptin modulates β cell expression of IL-1 receptor antagonist and release of IL-1β in human islets. Proc Natl Acad Sci USA 101:8138-8143
34. Kolb H, Mandrup-Poulsen T 2005 An immune origin of type 2 diabetes? Diabetologia 48:1038-1050
35. Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF 2003 Inflammatory cytokines and the risk to develop type 2 diabetes: results of the Prospective Population-Based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812-817
36. Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY 2007 Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356:1517-1526
37. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN 1988 Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37:1163-1167
38. Hirsch E, Irikura VM, Paul SM, Hirsh D 1996 Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA 93:11008-11013
39. Maedler K, Spinas GA, Dyntar D, Moritz W, Kaiser N, Donath MY 2001 Distinct effects of saturated and monounsaturated fatty acids on β-cell turn-over and function. Diabetes 50:69-76
40. Kaiser N, Corcos AP, Sarel I, Cerasi E 1991 Monolayer culture of adult rat pancreatic islets on extracellular matrix: modulation of B-cell function by chronic exposure to high glucose. Endocrinology 129:2067-2076
41. Warnick GR 1986 Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol 129:101-123
42. Maedler K, Fontana A, Ris F, Sergeev P, Toso C, Oberholzer J, Lehmann R, Bachmann F, Tasinato A, Spinas GA, Halban PA, and Donath MY 2002 FLIP switches Fas-mediated glucose signaling in human pancreatic β cells from apoptosis to cell replication. Proc Natl Acad Sci USA 99:8236-8241
43. Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, Rebuffe-Scrive M 1995 Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44:645-651
44. Maedler K, Schumann DM, Sauter N, Ellingsgaard H, Bosco D, Baertschiger R, Iwakura Y, Oberholzer J, Wollheim CB, Gauthier BR, Donath MY 2006 Low concentration of interleukin-1β induces FLICE-inhibitory protein-mediated β-cell proliferation in human pancreatic islets. Diabetes 55:2713-2722
45. Koerner A, Kratzsch J, Kiess W 2005 Adipocytokines: leptin - the classical, resistin-the controversial, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19:525-546
46. Reimer MK, Ahren B 2002 Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice. Diabetes 51(Suppl 1):S138-S143
47. Hull RL, Kodama K, Utzschneider KM, Carr DB, Prigeon RL, Kahn SE 2005 Dietary-fat-induced obesity in mice results in β cell hyperplasia but not increased insulin release: evidence for specificity of impaired β cell adaptation. Diabetologia 48:1350-1358
48. Sone H, Kagawa Y 2005 Pancreatic β cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 48:58-67
49. Maedler K, Spinas GA, Lehmann R, Sergeev P, Weber M, Fontana A, Kaiser N, Donath MY 2001 Glucose induces beta-cell apoptosis via upregulation of the Fas-receptor in human islets. Diabetes 50:1683-1690
50. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS 2006 TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025
51. Roehrich ME, Mooser V, Lenain V, Herz J, Nimpf J, Azhar S, Bideau M, Capponi A, Nicod P, Haefliger JA, Waeber G 2003 Insulin-secreting β-cell dysfunction induced by human lipoproteins. J Biol Chem 278:18368-18375
52. Sell H, Dietze-Schroeder D, Eckel J 2006 The adipocyte-myocyte axis in insulin resistance. Trends Endocrinol Metab 17:416-422
53. Simons PJ, van den Pangaart PS, van Roomen CP, Aerts JM, Boon L 2005 Cytokine-mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis: evidence that tumor necrosis factor-α- and interleukin-1β-treated human preadipocytes are potent leptin producers. Cytokine 32:94-103
54. Guzik TJ, Mangalat D, Korbut R 2006 Adipocytokines - novel link between inflammation and vascular function? J Physiol Pharmacol 57:505-528
55. Liuwantara D, Elliot M, Smith MW, Yam AO, Walters SN, Marino E, McShea A, Grey ST 2006 Nuclear factor-κB regulates β-cell death: a critical role for A20 in β-cell protection. Diabetes 55:2491-2501
56. Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J 1987 Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic β-cell cytotoxicity. J Immunol 139:4077-4082
57. Abbatecola AM, Ferrucci L, Grella R, Bandinelli S, Bonafe M, Barbieri M, Corsi AM, Lauretani F, Franceschi C, Paolisso G 2004 Diverse effect of inflammatory markers on insulin resistance and insulin-resistance syndrome in the elderly. J Am Geriatr Soc 52:399-404
58. Somm E, Cettour-Rose P, Asensio C, Charollais A, Klein M, Theander-Carrillo C, Juge-Aubry CE, Dayer JM, Nicklin MJ, Meda P, Rohner-Jeanrenaud F, Meier CA 2006 Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. Diabetologia 49:387-393